ArticleClinical drug investigation2019

Early Treatment of Systemic Juvenile Idiopathic Arthritis with Canakinumab and Complete Remission After 2 Years of Treatment Suspension: Case Report of an Adolescent Girl.

Maria Cristina Maggio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.